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Abstract Leptin, an adipocyte-derived hormone, regulates food
intake and energy expenditure in the hypothalamus via its re-
ceptor, member of the class I cytokine receptor family. Leptin
resistance has been observed in rodents and in humans. How-
ever, the mechanisms could not be explained in most cases of
human obesity, except for rare cases with mutations in the leptin
receptor. Recent reports demonstrated that ethanol inhibited the
Janus kinase/signal transducer and activator of transcription
(JAK/STAT) pathway activated by some members of the class
I cytokine receptor family. In this study, we examined the ef-
fects of ethanol on the leptin-induced JAK/STAT signaling
pathway using human hepatoma cell lines transiently expressing
long form of the leptin receptor. A 30 min pretreatment with
ethanol dose-dependently inhibited the leptin-induced STAT3
phosphorylation. Furthermore, to determine the time course of
ethanol inhibitory e¡ects, the cells were incubated in 10 mM
ethanol for various times. Partial inhibition of leptin-induced
STAT3 activation was seen after 1 min of treatment with etha-
nol and completely inhibited after 30 min pretreatment. SB
202190, a p38 mitogen-activated protein kinase (MAPK) inhib-
itor, partly prevented this inhibition by ethanol of leptin-induced
STAT3 activation. These ¢ndings suggest that ethanol time-
and dose-dependently inhibits the leptin action, in part via p38
MAPK. 3 2002 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Leptin, the product of the obese gene [1], is an adipocyte-
derived hormone that plays a central role in the control of
food intake and energy homeostasis [2^4]. Leptin has also
been shown to have e¡ects on peripheral cell types such as
pancreatic L cells [5], endothelial cells [6], hematopoietic cells
[7] and hepatocytes [8]. Leptin acts via receptors that are
homologous in sequence to class I cytokine receptors. These
include receptors for interleukin-6 (IL-6), leukocyte inhibitory
factor (LIF), and granulocyte colony stimulating factor (G-
CSF) [9,10]. The leptin receptor (OBR) gene encodes at least
¢ve alternatively spliced forms [10]. The spliced isoform
OBRb, referred to as the long form, is expressed at a high
level in the hypothalamus and at a low level in peripheral
tissues [10,11]. OBRb has a long cytoplasmic region contain-
ing several motifs for signal transduction through the Janus
kinase/signal transducer and activator of transcription (JAK/
STAT) pathway [12]. OBRb couples ligand binding to the
induction of tyrosine phosphorylation through its association
with JAK2. Receptor dimerization leads to JAK2 association,
tyrosine phosphorylation and activation of JAK2. The acti-
vated JAK2 phosphorylates a distal tyrosine (Y1138) on the
receptor, as well as STAT proteins. Although leptin appears
to activate STAT1, STAT3, STAT5 and STAT6, leptin only
activates STAT3 in the rodent hypothalamus [13]. The db/db
mice and Zucker rats (fa/fa), lacking functional leptin recep-
tors, have distinctive resistance to leptin [12,14]. Although
Clement et al. [15] identi¢ed mutations of the human OBR
gene, they are extremely rare [16]. In obese humans, elevated
serum leptin concentrations suggest reduced sensitivity to lep-
tin [17]. Several studies provided the mechanism for leptin
resistance [18^20]. However, the molecular basis for leptin
resistance in most cases of obesity in both humans and ro-
dents is still unknown. Several orexigenic molecules have been
reported and some of them antagonize leptin action in vivo
[2,21,22]. Little is known about the direct interaction between
these candidates as leptin, and leptin receptor-mediated sig-
nals. Alcohol, when consumed as an aperitif, generally in-
creases appetite. There have been several studies concerning
the e¡ects of ethanol intake on plasma leptin levels in rodents
and humans [23,24]. However, the e¡ects of ethanol on leptin
receptor signals remain unknown. Recently, Chen et al. [25]
reported that ethanol inhibits IL-6-induced STAT3 activation
in rat hepatocytes. In a more recent report, DeVito et al. [26]
demonstrated that prolactin (PRL)-induced JAK2 activation
was blocked by ethanol in rat astrocytes. The molecular mech-
anisms for these e¡ects of ethanol have not been established.
Several in vitro studies have demonstrated that ethanol stim-
ulates the activity of important kinases, including protein ki-
nase C (PKC) [27], p44/42 mitogen-activated protein kinase
(MAPK) [28] and p38 MAPK [29]. In this study, we examined
the e¡ects of ethanol and p38 MAPK on the leptin-induced
JAK/STAT pathway in cultured human hepatoma cells.
2. Materials and methods
2.1. Materials
Recombinant mouse leptin was obtained from RpD Systems (Min-
neapolis, MN, USA). The JAK2 expression vector was a generous gift
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of Dr. Rikiro Fukunaga (Osaka University, Osaka, Japan). All re-
agents for cell culture and transfection were obtained from Life Tech-
nologies (Gaithersburg, MD, USA). Anti-JAK2, anti-STAT3 and
anti-phospho-leptin receptor (Y1138) antibodies were from Upstate
Biotechnology (Lake Placid, NY, USA). Anti-phosphospeci¢c
STAT3 antibody was from New England Biolabs (Beverly, MA,
USA). Anti-phosphospeci¢c JAK2 antibody was from Bio Source
(Camarillo, CA, USA). Anti-leptin receptor antibody was a generous
gift of Dr. Radek C. Skoda (Basel University, Basel, Switzerland).
Nitrocellulose membranes were from Scleicher and Schuell (Keene,
NH, USA). The enhanced chemiluminescence (ECL) detection system,
anti-rabbit IgG-conjugated horseradish peroxidase was purchased
from Amersham Pharmacia Biotech (Piscataway, NJ, USA). SB
202190, a p38 MAPK inhibitor, was purchased from Calbiochem
(La Jolla, CA, USA).
2.2. Cell culture and transient transfection
Huh7 cells were grown in RPMI supplemented with 5% fetal calf
serum, 50 U/ml penicillin G and 50 Wg/ml streptomycin under 5%
CO2. 293 cells were grown in Dulbecco’s modi¢ed Eagle’s medium
(DMEM, high glucose) supplemented with 10% fetal calf serum, 50 U/
ml penicillin G and 50 Wg/ml streptomycin under 5% CO2. The cDNA
encoding mouse leptin receptor long form was generated as described
previously [30]. For Western blotting experiments, cells were grown in
six-well plates and transfected using 5 Wl of LipofectAMINE (Life
Technologies, Rockville, MD, USA) and 2 Wg of DNA per well.
48^72 h after transfection, including 15 h of serum deprivation, the
cells were incubated for 15 min with 1 nM leptin as previously de-
scribed [31]. Cells were then washed three times with ice-cold phos-
phate-bu¡ered saline (PBS) and dissolved in lysis bu¡er (1% Nonidet
P-40, 5 mM EDTA, 10 mM Na4P2O7, 100 mM NaF, 2 mM Na3VO4,
10 Wg/ml aprotinin, 10 Wg/ml leupeptin, 1 mM phenylmethylsulfonyl
£uoride and 20 mM Tris).
2.3. Immunoprecipitation and immunoblotting
The cell lysates were centrifuged at 20 000Ug at 4‡C for 20 min.
The supernatants were incubated with anti-OBR antibody and protein
A agarose beads on a rotating wheel at 4‡C overnight. Immune com-
plexes were collected by centrifugation and washed three times in lysis
bu¡er before the samples were separated by sodium dodecyl sulfate^
polyacrylamide gel electrophoresis (SDS^PAGE) and transferred to
nitrocellulose membranes. The membranes were blocked with 5%
non-fat dry milk in Tris-bu¡ered saline/0.1% Tween 20 (TBST) at
room temperature for 2 h and then incubated with antibodies in 5%
milk overnight at 4‡C. After three washes, for 5 min each in TBST at
room temperature, the membranes were incubated with horseradish
peroxidase-conjugated anti-rabbit immunoglobulin (1:1000) in 1%
milk for 1.5 h at room temperature and again washed three times
with TBST. The targeted proteins were detected using enhanced
chemiluminescence (ECL) following the instructions of the manufac-
turer. The membranes were stripped in Restore Western Blot Strip-
ping Bu¡er (Pierce, Rockford, IL, USA) according to the manufac-
turer’s instructions.
3. Results and discussion
Recent reports demonstrated that ethanol inhibited the
JAK/STAT pathway activated by some members of the class
I cytokine receptor family [25,26]. In the present study, we
examined the e¡ects of ethanol on the leptin-induced JAK/
STAT signaling pathway using human hepatoma cell lines.
We tested for the presence of endogenous functional leptin
receptors. The untransfected Huh7 were stimulated with
1 nM leptin for 5^30 min at room temperature and cell lysates
were subsequently analyzed by Western blotting. Neither anti-
phospho-STAT3 (Tyr705) nor anti-phosphotyrosine antibod-
ies detected any speci¢c bands in leptin-stimulated untrans-
fected cells (data not shown). We transiently transfected
OBRb cDNA to Huh7 cells. The Huh7 cells expressing
OBRb were stimulated with 1^100 nM leptin at room temper-
ature for 5^30 min. The cell lysates were immunoblotted with
anti-phospho-STAT3. The phosphorylated endogenous
STAT3 bands were detected after 5 min of leptin stimulation
and peaked at 15 min (data not shown). To determine the
dose response of the inhibitory e¡ects of ethanol on leptin-
induced STAT3 phosphorylation, the cells expressing OBRb
were preincubated with 0^100 mM ethanol for 30 min at
37‡C, followed by leptin stimulation for 15 min at room tem-
perature. After a 30 min pretreatment with ethanol, 50% in-
hibition was observed at 0.1 mM and complete inhibition at
100 mM ethanol, indicating a dose-dependent inhibition of
the leptin-induced STAT3 phosphorylation (Fig. 1A). Fur-
thermore to determine the time course of ethanol inhibitory
e¡ects on leptin-induced STAT3 phosphorylation, the cells
were incubated in 100 mM ethanol for various times. Partial
inhibition of STAT3 activation was seen after a 1 min pre-
treatment with ethanol, and completely inhibited after 30 min
pretreatment (Fig. 1B). To test whether ethanol decreased
levels of STAT3 protein in Huh7 cells, we stripped and re-
probed both membranes with anti-STAT3 antibodies. Ethanol
did not a¡ect the amounts of STAT3 protein (Fig. 1B). These
¢ndings suggest that ethanol time-dependently attenuates lep-
tin-induced STAT3 phosphorylation in Huh7. Leptin binding
to OBRb results in the tyrosine phosphorylation of tyrosine
residues on the intracellular domain of OBRb. We investi-
gated the e¡ects of ethanol on the tyrosine phosphorylation
of OBRb. 293 cells transiently expressing OBRb were pre-
treated with or without 100 mM ethanol for 30 min, followed
by leptin stimulation for 10 min at room temperature. The
clari¢ed cell lysates were subjected to immunoprecipitation
and immunoblotting. In 293 cells expressing OBRb, ethanol
inhibited the tyrosine phosphorylation of OBRb as well as the
leptin-induced STAT3 phosphorylation (Fig. 2A, B). Chen et
al. [25] have shown that ethanol rapidly and dose-dependently
Fig. 1. Ethanol inhibits leptin-induced STAT3 activation in a dose-
and time-dependent manner. A: Huh7 cells expressing OBRb were
incubated with various concentrations of ethanol for 30 min at
37‡C, and subsequently stimulated with 1 nM of leptin for 15 min.
Cell extracts were separated by 8% SDS^PAGE and analyzed by
immunoblotting with an anti-phosphospeci¢c STAT3 antibody, then
with an anti-STAT3 antibody. B: Huh7 cells expressing OBRb were
incubated with 100 mM of ethanol for various times at 37‡C, and
subsequently stimulated with 1 nM of leptin for 15 min.
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inhibited IL-6-induced STAT3 activation in isolated rat hepa-
tocytes. The inhibitory e¡ects of ethanol on STAT3 phos-
phorylation were not due to inhibition of JAK2 activation.
In this study, IL-6-induced STAT3 activation was completely
inhibited at 100 mM ethanol and only slightly at 10 mM
ethanol. We showed that leptin-induced STAT3 activation
was completely inhibited by ethanol at lower concentration
(10 mM). This concentration in blood is within the physio-
logical relevant range, and is associated with impaired mental
capabilities and coordination in humans. Agapejev et al. [32]
measured the concentration of ethanol in samples of blood
and CSF from patients under pathological conditions. In their
study, the concentration of ethanol in blood was similar to
that in CSF. These results suggest that ethanol a¡ects the
leptin e¡ects in peripheral tissue, as well as the central nervous
system. It has been reported that ethanol inhibited the pro-
lactin-induced activation of JAK2, and subsequently, inhib-
ited STAT3 phosphorylation in cultured astrocytes [26]. Re-
cently, a family of cytokine-inducible proteins has been
identi¢ed that appear to act as negative regulators for cyto-
kine receptor signaling [33]. Bjorbaek et al. reported that lep-
tin induced the expression of SOCS-3 mRNA in the hypothal-
amus [19] and the expression of SOCS-3 inhibited leptin-
induced JAK2 activation in CHO cells [34]. To investigate
whether ethanol inhibits leptin-induced JAK2 phosphoryla-
tion, Huh7 treated with 100 mM ethanol were immunoblotted
with anti-phoshospeci¢c JAK2 (Y1007=1008). Ethanol did not
a¡ect leptin-induced tyrosine phosphorylation of JAK2 in
Huh7 cells (Fig. 3). No inhibitory e¡ects of ethanol on
JAK2 phosphorylation have been seen in 293 cells expressing
OBRb (data not shown). Phosphorylated tyrosine at position
1007 is critical for JAK2 activity [35]. The results suggest
ethanol directly attenuates leptin-induced STAT3 and OBRb
phosphorylation without inhibition of JAK2. We then exam-
ined whether the leptin-induced STAT3 phosphorylation
could recover after the removal of ethanol from the medium.
The cells were treated with 100 mM of ethanol for 30 min to
inhibit the leptin-induced STAT3 phosphorylation, then
washed three times with PBS and cultured for various times
in serum-free RPMI 1640. The leptin-induced STAT3 phos-
phorylation gradually returned to the same level as ethanol-
untreated cells, 12 h after the removal of the ethanol from the
medium (Fig. 4). The mechanism of the inhibitory e¡ects of
ethanol on leptin-induced STAT3 phosphorylation was then
investigated. Since these e¡ects occurred so rapidly we specu-
lated that the mechanism does not require de novo protein
synthesis. Ethanol has been shown to modulate the activity of
several protein kinases, including PKC [27], JNK [36] and
MAPK [37]. It has been reported that PKC inhibitor prevents
ethanol inhibition of IL-6-induced STAT3 activation in rat
hepatocytes [25]. To determine whether the inhibitory e¡ects
of ethanol on leptin-induced STAT3 phosphorylation are
Fig. 2. Ethanol inhibits leptin-induced OBRb phosphorylation.
A: 293 cells expressing OBRb were incubated with 100 mM ethanol
for 30 min at 37‡C, and subsequently stimulated with 1 nM of lep-
tin for 10 min. Cell extracts were immunoprecipitated with anti-
OBR antibody and immunoblotted with anti-phospho-OBR anti-
body. B: 293 cells expressing OBRb were incubated with 100 mM
ethanol for 30 min at 37‡C, and subsequently stimulated with 1 nM
of leptin for 15 min. Cell extracts were immunoblotted with anti-
phospho-STAT3 or STAT3 antibody.
Fig. 3. Ethanol does not inhibit leptin-induced JAK2 phosphoryla-
tion. Huh7 cells were co-transfected with OBRb cDNA (1.5 Wg) and
JAK2 cDNA (0.5 Wg). Cells expressing OBRb and JAK2 were incu-
bated with 100 mM of ethanol for 30 min at 37‡C, and subse-
quently stimulated with 1 nM of leptin for 5 min. Cell extracts were
separated by 8% SDS^PAGE and analyzed by immunoblotting with
an anti-phosphospeci¢c JAK2 antibody.
Fig. 4. Inhibitory e¡ects of ethanol are reversible. Cells were incuba-
ted with 100 mM of ethanol for 30 min to inhibit the leptin-induced
STAT3 phosphorylation and cultured for various times in serum-
free RPMI 1640. The leptin-induced STAT3 phosphorylation re-
turned to the same level as ethanol-untreated cells 12 h after the re-
moval of the ethanol from the medium.
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mediated through these kinases, we investigated the inhibitory
e¡ects of ethanol using the speci¢c inhibitors of PKC and
MAPK. Rottlerin, an inhibitor of PKC, and PD 98059, an
inhibitor of MEK, had no e¡ects on the ethanol inhibition of
leptin-induced STAT3 activation (data not shown). In con-
trast, when 1 WM of SB 202190, a p38 MAPK inhibitor,
was added to the cells prior to treatment with ethanol, SB
202190 partially blocked the ethanol inhibition of leptin-in-
duced STAT3 activation (Fig. 5). SB 202190 by itself had no
e¡ects on the STAT3 phosphorylation. These ¢ndings suggest
that p38 MAPK is involved in the ethanol inhibition of leptin-
induced STAT3 activation. p38 MAPK is known to be asso-
ciated with in£ammatory cytokines and environmental stress-
es. A recent study has identi¢ed p38 MAPK activated by
ethanol in perfused rat liver cells [29]. In this study, p38
MAPK was rapidly activated in response to isoosmotic cell
swelling induced by ethanol. In the central nervous system,
the activation of p38 MAPK has been demonstrated, and is
considered to be a part of the neuronal stress response [38].
Thus ethanol may inhibit leptin action via p38 MAPK in
neuronal cells expressing OBRb. To test this hypothesis, fur-
ther studies will be required in vivo. In summary, we exam-
ined the e¡ects of ethanol on the leptin-induced JAK/STAT
signaling pathway in Huh7 cells transiently expressing OBRb.
The leptin-induced STAT3 phosphorylation was dose- and
time-dependently inhibited by pretreatment with ethanol.
Ethanol has no e¡ect on the amount of STAT3 protein or
leptin-induced JAK2 phosphorylation. p38 MAPK may play
a role in these inhibitory e¡ects of ethanol on leptin-induced
STAT3 phosphorylation.
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